Condition
Immunisation Against Streptococcus Pneumoniae
Total Trials
2
Recruiting
0
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 2 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
Early P 1 (1)
Trial Status
Withdrawn1
Active Not Recruiting1
Clinical Trials (2)
Showing 2 of 2 trials
NCT06975319Early Phase 1Active Not Recruiting
Phase I Study With V-212 Vaccinations in Healthy Adult Volunteers
NCT01803425WithdrawnPrimary
Post-marketing Safety Study of GlaxoSmithKline (GSK) Biologicals' Synflorix™ Vaccine, in Healthy Infants and Children in Sri Lanka
Showing all 2 trials